» Articles » PMID: 36762101

Nalmefene Vs. Dexmedetomidine for Prevention of Postoperative Hyperalgesia in Patients Undergoing Laparoscopic Gynecological Surgery with Remifentanil Infusion: A Randomized Double-blind Controlled Trial

Overview
Journal Front Pharmacol
Date 2023 Feb 10
PMID 36762101
Authors
Affiliations
Soon will be listed here.
Abstract

Intraoperative remifentanil infusion may paradoxically induce post-surgical hyperalgesia. Dexmedetomidine reportedly reduces opioid-induced hyperalgesia. Nalmefene selectively reverses several side-effects of opioids without impairing analgesia. Herein, this randomized, double-blind controlled trial investigated whether nalmefene, dexmedetomidine, and both drugs combined prevent remifentanil-induced hyperalgesia. One hundred and fifty patients undergoing elective laparoscopic gynecological surgery under desflurane anesthesia randomly received either intraoperative sufentanil 0.20 μg kg (Group S), or remifentanil 0.20 μg kg min (Group R), or remifentanil and pre-anesthesia nalmefene 0.20 μg kg (Group N), or remifentanil and pre-anesthesia dexmedetomidine 0.50 μg kg (Group D), or remifentanil and the combination of dexmedetomidine 0.25 μg kg and nalmefene 0.10 μg kg (Group DN). The threshold of postoperative mechanical hyperalgesia (primary outcome) was measured with von Frey filaments. We also recorded pain intensity, analgesic consumptions, hyperalgesic area, and side-effects for 24 h postoperatively. Compared with Group S, remifentanil reduced hyperalgesic threshold on the forearm [mean 89.4 (SD 13.7) vs. 62.2 (10.7) g, < 0.001] at postoperative 24 h. Pain threshold on the forearm at postoperative 24 h was significantly lower in Group R than in Groups N, D and DN [62.2 (10.7) vs. 71.1 (12.3), 72.4 (12.9) and 78.0 (13.8) g]. Compared with Group R, Postoperative pain intensity, analgesic consumption and hyperalgesic area were lower likewise in Groups D and DN. However, the incidence of intraoperative bradycardia was lower and post-anesthesia recovery time was shorter in Group DN than Group D. Preoperative therapy of dexmedetomidine and nalmefene combined attenuates postoperative hyperalgesia in patients undergoing laparoscopic gynecological surgery under desflurane-remifentanil anesthesia.

Citing Articles

Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder.

Green M, Veltri C, Grundmann O Subst Abuse Rehabil. 2024; 15:43-57.

PMID: 38585160 PMC: 10999209. DOI: 10.2147/SAR.S431270.


Trajectory of pain threshold and its association with acute pain after thoracic surgery: a prospective observational study.

Wang F, Ou M, Zhu Y, Zhu T, Hao X J Cardiothorac Surg. 2023; 18(1):326.

PMID: 37964267 PMC: 10648379. DOI: 10.1186/s13019-023-02424-w.

References
1.
Fechner J, Ihmsen H, Schuttler J, Jeleazcov C . The impact of intra-operative sufentanil dosing on post-operative pain, hyperalgesia and morphine consumption after cardiac surgery. Eur J Pain. 2012; 17(4):562-70. DOI: 10.1002/j.1532-2149.2012.00211.x. View

2.
Zhang L, Shu R, Zhao Q, Li Y, Wang C, Wang H . Preoperative But Not Postoperative Flurbiprofen Axetil Alleviates Remifentanil-induced Hyperalgesia After Laparoscopic Gynecological Surgery: A Prospective, Randomized, Double-blinded, Trial. Clin J Pain. 2016; 33(5):435-442. DOI: 10.1097/AJP.0000000000000416. View

3.
Araldi D, Ferrari L, Levine J . Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain. J Neurosci. 2015; 35(36):12502-17. PMC: 4563038. DOI: 10.1523/JNEUROSCI.1673-15.2015. View

4.
Blaudszun G, Lysakowski C, Elia N, Tramer M . Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2012; 116(6):1312-22. DOI: 10.1097/ALN.0b013e31825681cb. View

5.
Koo C, Yoon S, Kim B, Cho Y, Kim T, Jeon Y . Intraoperative naloxone reduces remifentanil-induced postoperative hyperalgesia but not pain: a randomized controlled trial. Br J Anaesth. 2017; 119(6):1161-1168. DOI: 10.1093/bja/aex253. View